J 2021

Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins

BOSÁK, Juraj, Matěj HRALA, Lenka MICENKOVÁ and David ŠMAJS

Basic information

Original name

Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins

Authors

BOSÁK, Juraj (703 Slovakia, belonging to the institution), Matěj HRALA (203 Czech Republic, belonging to the institution), Lenka MICENKOVÁ (703 Slovakia, belonging to the institution) and David ŠMAJS (203 Czech Republic, guarantor, belonging to the institution)

Edition

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, ABINGDON, TAYLOR & FRANCIS LTD, 2021, 1478-7210

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10606 Microbiology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.854

RIV identification code

RIV/00216224:14110/21:00120740

Organization unit

Faculty of Medicine

DOI

UT WoS

000571964600001

Keywords in English

Antimicrobials; bacteriocin; colicin; microcin; Escherichia; E; coli; probiotic; Shigella; virulence; diarrhea

Tags

Tags

International impact, Reviewed
Změněno: 21/2/2022 12:56, Mgr. Tereza Miškechová

Abstract

V originále

Introduction The emergence and spread of antibiotic resistance among pathogenic bacteria drives the search for alternative antimicrobial therapies. Bacteriocins represent a potential alternative to antibiotic treatment. In contrast to antibiotics, bacteriocins are peptides or proteins that have relatively narrow spectra of antibacterial activities and are produced by a wide range of bacterial species. Bacteriocins ofEscherichia coliare historically classified as microcins and colicins, and, until now, more than 30 different bacteriocin types have been identified and characterized. Areas covered We performed bibliographical searches of online databases to review the literature regarding bacteriocins produced byE. coliwith respect to their occurrence, bacteriocin role in bacterial colonization and pathogenicity, and application of their antimicrobial effect. Expert opinion The potential use of bacteriocins for applications in human and animal medicine and the food industry includes (i) the use of bacteriocin-producing probiotic strains, (ii) recombinant production in plants and application in food, and (iii) application of purified bacteriocins.

Links

MUNI/A/1325/2020, interní kód MU
Name: Biomedicínské vědy
Investor: Masaryk University
ROZV/23/LF13/2019, interní kód MU
Name: Terapeutický potenciál bakteriocinogenních probiotik v léčbě kolibakterióz
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
ROZV/28/LF15/2020, interní kód MU
Name: Role bakteriocinů u infekcí močových cest
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects